(Q44232430)

1 December 2017

A randomized controlled trial of intravenous montelukast in acute asthma (English)

1 reference

randomized controlled trial

1 December 2017

1 reference

1 reference

1

Carlos A Camargo

1 reference

1 December 2017

Howard A Smithline

2

1 reference

1 December 2017

Marie-Pierre Malice

series ordinal

3

1 reference

1 December 2017

Stuart A Green

series ordinal

4

1 reference

1 December 2017

Theodore F Reiss

series ordinal

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

27 November 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

1 December 2017

1 reference

1 December 2017

167

1 reference

1 December 2017

4

1 reference

1 December 2017

528-533

1 reference

The work impact of asthma and rhinitis: findings from a population-based survey

1 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Observations on the effects of aerosolized albuterol in acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

A meta-analysis of the effects of ipratropium bromide in adults with acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

The role of anticholinergics in acute asthma treatment: an evidence-based evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

The influence of parasympatholytics on the resolution of acute attacks of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Persistent increase in plasma and urinary leukotrienes after acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Hyperkalemia and ionized hypocalcemia during cardiac arrest and resuscitation: possible culprits for postcountershock arrhythmias?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Comparison of two dosage regimens of albuterol in acute asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Trends in the cost of illness for asthma in the United States, 1985-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Health-care costs of inner-city patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Ipratropium bromide in emergency management of acute asthma exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

Recovery of Leukotriene E4from the Urine of Patients with Airway Obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-802OC

10.1164/RCCM.200208-802OC

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference